Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palpebral dacryoadenectomy for epiphora.

A Hornblass1, C Guberina, B J Herschorn

  • 1Department of Ophthalmic Plastic, Manhattan Eye, Ear and Throat Hospital, New York, NY 10021.

Ophthalmic Plastic and Reconstructive Surgery
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enlarged pupillary membranes.

Journal of pediatric ophthalmology and strabismus·2014
Same author

Tarsal switch procedure for the surgical rehabilitation of the eyelid and socket deficiencies of the anophthalmic socket.

Ophthalmic plastic and reconstructive surgery·1999
Same author

Sclerosing sweat duct carcinoma of the eyelid margin: unusual presentation of a rare tumor.

Ophthalmology·1999
Same author

Pseudomonal eyelid necrosis: clinical characteristics and review of the literature.

Ophthalmic plastic and reconstructive surgery·1998
Same author

Infantile myofibromatosis of orbital bone. A case report with computed tomography, magnetic resonance imaging, and histologic findings.

Ophthalmology·1997
Same author

Intravascular papillary endothelial hyperplasia: collection of four cases and a review of the literature.

Ophthalmic plastic and reconstructive surgery·1997
Same journal

Porocarcinoma Arising in a Long-Standing Eviscerated Socket.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Hyper Immunoglobulin E Syndrome With Conjunctival Molluscum Contagiosum.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Ethmoiditis Mimicking Acute Dacryocystitis-An Underreported Pathology.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Orbital Inflammatory Syndrome Associated with Bispecific T-Cell Engager Therapy: Case and Literature Review.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

A Rare Pedunculated Lobular Capillary Hemangioma of the Conjunctiva.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Core Oculoplastic Procedure Skills for the Comprehensive Ophthalmologist: A Consensus by Delphi Methodology.

Ophthalmic plastic and reconstructive surgery·2026
See all related articles

Palpebral dacryoadenectomy effectively relieved epiphora in most patients with patent lacrimal systems. Some patients experienced dry eye post-surgery.

Area of Science:

  • Ophthalmology
  • Surgical Techniques

Background:

  • Epiphora, or excessive tearing, can significantly impact quality of life.
  • Palpebral dacryoadenectomy (PDA) is a surgical option for managing epiphora.

Purpose of the Study:

  • To evaluate the efficacy of palpebral dacryoadenectomy (PDA) in relieving epiphora.
  • To assess symptomatic relief and objective measures post-surgery.

Main Methods:

  • A prospective study involving 37 patients undergoing PDA for epiphora.
  • Evaluation included subjective symptomatic relief and objective Schirmer testing.
  • Surgical technique for PDA was described.

Main Results:

  • 62% of patients achieved complete epiphora relief after PDA.

Related Experiment Videos

  • 19% experienced partial improvement in epiphora.
  • 76% showed a decrease in Schirmer test results, indicating reduced tear production.
  • 14% reported dry eye symptoms and foreign body sensation post-procedure.

    • Conclusions:

    • Palpebral dacryoadenectomy is an effective treatment for epiphora in patients with patent lacrimal excretory systems.
    • While generally successful, a subset of patients may experience dry eye complications.